Kernell A, Larsson Y, Ludvigsson J, Tenland T
Acta Endocrinol Suppl (Copenh). 1980;238:67-74.
A group of 26 juvenile diabetics, 8-22 years old with a mean duration of diabetes of 7.8 +/- 5.7 years were examined by vitreous fluorophotometry. Eleven non-diabetic healthy individuals, 12-27 years old, served as controls. Vitreous fluorescein concentrations one hour after injection of fluorescein were higher in the diabetics than in the controls indicating an abnormal blood-retinal barrier. In diabetes beyond the partial remission period a pronounced leakage of fluorescein into the vitreous body occurred, while diabetics still in partial remission showed no such abnormal leakage. There were no significant correlations between a defect blood-retinal barrier and duration or age at onset of diabetes. Some diabetic patients showed an abnormal leakage with a duration of diabetes less than 2 years, while some other patients with a duration of more than 16 years did not have an abnormal blood-retinal barrier. The diabetics with defect blood-retinal barrier had a lower glucosuria index during the last year, indicating a more inadequate metabolic control than those patients who had a normal barrier. There was no relation between the actual blood-glucose value during the examination and abnormal leakage. In some diabetics, all beyond partial remission significantly elevated fluorescein concentrations were also found in the anterior parts of the vitreous body, indicating a break-down of the blood-aqueous barrier as well. In conclusion, vitreous fluorophotometry provides information about early, functional and possibly reversible retinal changes in juvenile diabetes. The observation that the blood-retinal barrier remained intact during the remission period supports the hypothesis that normoglycemic metabolic control is of importance for the preservation of a normal blood-retinal barrier function.
对一组26名8至22岁的青少年糖尿病患者进行了玻璃体荧光光度测定,他们的糖尿病平均病程为7.8±5.7年。11名12至27岁的非糖尿病健康个体作为对照。糖尿病患者注射荧光素1小时后的玻璃体荧光素浓度高于对照组,表明血视网膜屏障异常。在糖尿病超过部分缓解期时,荧光素明显渗漏到玻璃体中,而仍处于部分缓解期的糖尿病患者则未出现这种异常渗漏。血视网膜屏障缺陷与糖尿病病程或发病年龄之间无显著相关性。一些糖尿病患者病程不到2年就出现了异常渗漏,而其他一些病程超过16年的患者却没有血视网膜屏障异常。血视网膜屏障有缺陷的糖尿病患者在过去一年中的糖尿指数较低,这表明其代谢控制比血视网膜屏障正常的患者更差。检查期间的实际血糖值与异常渗漏之间没有关系。在一些糖尿病患者中,所有超过部分缓解期的患者在玻璃体前部也发现荧光素浓度显著升高,这也表明血房水屏障也遭到了破坏。总之,玻璃体荧光光度测定提供了有关青少年糖尿病早期、功能性以及可能可逆的视网膜变化的信息。在缓解期血视网膜屏障保持完整这一观察结果支持了以下假说,即血糖正常的代谢控制对于维持正常的血视网膜屏障功能很重要。